CDKN2A and biliary tract cancer: In biliary tract cancers (BTCs), which encompass gallbladder cancer, intrahepatic cholangiocarcinoma (ICC), and extrahepatic cholangiocarcinoma (EHC), alterations in the CDKN2A gene are frequently observed.